0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover0.00%IV113.41%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.93Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Aura Biosciences Stock Discussion
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-SAR in Patients With Non-Muscle-Invasive Bladder Cancer (Nmibc) in Ongoing Phase 1 Trial! No adverse events
Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma
Aura Biosciences (NASDAQ: AURA) reported positive Phase 2 end of study results for bel-sar (AU-011) in treating early-stage choroidal melanoma (CM). The study showed an 80% tumor control rate and 90% visual acuity preservationamong Phase 3-eligible patients. Bel-sar demonstrated a highly favorable safety profile with no tre...
via @Lnova 📊⚡️📊
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting
In reaction to earnings/guidance:
• $Nutanix (NTNX.US)$ +15.4%, $Pure Storage (PSTG.US)$ +6.8%, $Credo Technology (CRDO.US)$ +5.9%, $Signet Jewelers (SIG.US)$ +3.6%, $SentinelOne (S.US)$ +3.4%, $Five Below (FIVE.US)$ +3.2%, $GMS Inc (GMS.US)$ +1.7%, $The Scotts Miracle (SMG.US)$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources (TRQ.US)$ +12.3% (to be acquired by Rio T...
• $Aura Biosciences (AURA.US)$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors (HYZN.US)$ +8.2% (to collaborate with $Schlumberger (SLB.US)$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises (APOG.US)$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc (GMS.US)$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants (DRI.US)$ +4.2% (In reaction to earnings/gui...
No comment yet